LPL Financial’s DexCom DXCM Stock Holding History

LPL Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,000	Closed	-$996K	–	6037
2025 Q4	$996K	Buy	15,000 +3,000	+25%	+$194K	﹤0.01%	4083
2025 Q3	$807K	Buy	+12,000	New	+$950K	﹤0.01%	4208

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LPL Financial's DXCM Position: Q1 2026 in Review

LPL Financial increased its DexCom (DXCM) stake by 98% in Q1 2026, buying an estimated $12.6M and bringing the position to 365,365 shares worth $22.9M. The position accounts for 0.01% of the portfolio, ranked #1369.

LPL Financial first reported a position in DXCM in Q2 2015 and has held it in 41 quarters since. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

LPL Financial held 365,365 shares of DexCom worth $22.9M as of Q1 2026.
LPL Financial bought 180,471 DexCom shares in Q1 2026, an estimated $12.6M.
DexCom made up 0.01% of LPL Financial's portfolio in Q1 2026, its #1369 holding.
LPL Financial first reported a position in DexCom in Q2 2015 and has held it in 41 quarters since.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.